Drugs known as GLP-1 receptor agonists have recently become very popular, not only for treating diabetes but also for helping people lose weight.
However, a new large review study suggests that while these medicines have clear benefits, they also come with important risks that people should understand.
The study, published in JAMA Network Open, looked at a very large amount of data to better understand how these drugs affect the body beyond their main use.
Researchers reviewed 60 previous analyses, which together included more than 1,700 clinical trials and over 3.5 million participants. This makes the findings quite strong, as they are based on a large number of studies.
GLP-1 drugs work by copying the action of a natural hormone in the body. This hormone is released after eating and helps control blood sugar and appetite.
These medicines slow down how quickly food leaves the stomach, which makes people feel full for longer. They also help the body release insulin when needed. Because of this, they are effective for managing diabetes and supporting weight loss.
However, the review found that these drugs are strongly linked to digestive side effects. Many people taking them experience nausea, vomiting, or diarrhea. These side effects can be uncomfortable and may lead some people to stop using the medication.
At the same time, the study found some surprising possible benefits. The drugs may help protect against serious infections. They may also have positive effects on lung health by reducing inflammation in the airways. In addition, weight loss caused by these drugs may improve conditions such as sleep apnea.
There were also early signs that GLP-1 drugs might benefit the brain. Some evidence suggests they could reduce the risk of dementia by improving blood flow and reducing harmful substances in the brain. There were also hints that these drugs could support bone health and reduce the risk of fractures.
However, the researchers stress that these possible benefits are not yet fully proven. More studies are needed to confirm them. At this stage, the evidence is still considered early and exploratory.
The study focused only on effects beyond the usual benefits related to blood sugar, heart health, and kidney function. This is important because most previous research has focused mainly on those areas.
From an analytical point of view, this study is valuable because it brings together a very large amount of data. This helps provide a clearer picture of both the risks and possible wider benefits of these drugs.
However, there are also limitations. Because the study combines results from many different trials, the findings may vary depending on how each trial was designed. Also, some of the reported benefits are based on indirect evidence and need stronger confirmation.
In conclusion, GLP-1 drugs remain an important option for treating diabetes and supporting weight loss. However, patients and doctors should be aware of the common digestive side effects. At the same time, the possible wider health benefits are interesting but still uncertain.
As the use of these drugs continues to grow, more research will be needed to fully understand their long-term effects on the body.
If you care about weight loss, please read studies that hop extract could reduce belly fat in overweight people, and early time-restricted eating could help lose weight .
For more health information, please see recent studies about a simple path to weight loss, and results showing a non-invasive treatment for obesity and diabetes.
Source: JAMA Network Open.
